152 related articles for article (PubMed ID: 12920204)
1. Influence of agonist efficacy and receptor phosphorylation on antagonist affinity measurements: differences between second messenger and reporter gene responses.
Baker JG; Hall IP; Hill SJ
Mol Pharmacol; 2003 Sep; 64(3):679-88. PubMed ID: 12920204
[TBL] [Abstract][Full Text] [Related]
2. Agonist and inverse agonist actions of beta-blockers at the human beta 2-adrenoceptor provide evidence for agonist-directed signaling.
Baker JG; Hall IP; Hill SJ
Mol Pharmacol; 2003 Dec; 64(6):1357-69. PubMed ID: 14645666
[TBL] [Abstract][Full Text] [Related]
3. Temporal characteristics of cAMP response element-mediated gene transcription: requirement for sustained cAMP production.
Baker JG; Hall IP; Hill SJ
Mol Pharmacol; 2004 Apr; 65(4):986-98. PubMed ID: 15044629
[TBL] [Abstract][Full Text] [Related]
4. Influence of receptor number on the stimulation by salmeterol of gene transcription in CHO-K1 cells transfected with the human beta2-adrenoceptor.
McDonnell J; Latif ML; Rees ES; Bevan NJ; Hill SJ
Br J Pharmacol; 1998 Oct; 125(4):717-26. PubMed ID: 9831907
[TBL] [Abstract][Full Text] [Related]
5. Differential contribution of two serine residues of wild type and constitutively active beta2-adrenoceptors to the interaction with beta2-selective agonists.
Kikkawa H; Kurose H; Isogaya M; Sato Y; Nagao T
Br J Pharmacol; 1997 Jul; 121(6):1059-64. PubMed ID: 9249239
[TBL] [Abstract][Full Text] [Related]
6. The effect of assay formats on the estimation of melanocortin agonist affinity and efficacy using the operation model of agonism.
Simon S; Young TJ; Nickolls SA
Eur J Pharmacol; 2009 Aug; 615(1-3):33-9. PubMed ID: 19446549
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a secondary state of the human beta3-adrenoceptor.
Baker JG
Mol Pharmacol; 2005 Dec; 68(6):1645-55. PubMed ID: 16129733
[TBL] [Abstract][Full Text] [Related]
8. Effects of beta 2-agonist- and dexamethasone-treatment on relaxation and regulation of beta-adrenoceptors in human bronchi and lung tissue.
Hauck RW; Harth M; Schulz C; Präuer H; Böhm M; Schömig A
Br J Pharmacol; 1997 Aug; 121(8):1523-30. PubMed ID: 9283684
[TBL] [Abstract][Full Text] [Related]
9. Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies.
Tran TM; Friedman J; Qunaibi E; Baameur F; Moore RH; Clark RB
Mol Pharmacol; 2004 Jan; 65(1):196-206. PubMed ID: 14722251
[TBL] [Abstract][Full Text] [Related]
10. A study of antagonist affinities for the human histamine H2 receptor.
Baker JG
Br J Pharmacol; 2008 Mar; 153(5):1011-21. PubMed ID: 18157166
[TBL] [Abstract][Full Text] [Related]
11. Phenoxybenzamine and benextramine, but not 4-diphenylacetoxy-N-[2-chloroethyl]piperidine hydrochloride, display irreversible noncompetitive antagonism at G protein-coupled receptors.
Bodenstein J; Venter DP; Brink CB
J Pharmacol Exp Ther; 2005 Aug; 314(2):891-905. PubMed ID: 15857948
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of inverse agonists in cells overexpressing a constitutively active beta2-adrenoceptor and type II adenylyl cyclase.
Stevens PA; Milligan G
Br J Pharmacol; 1998 Jan; 123(2):335-43. PubMed ID: 9489623
[TBL] [Abstract][Full Text] [Related]
13. Different mechanisms of action of beta2-adrenergic receptor agonists: a comparison of reproterol, fenoterol and salbutamol on monocyte cyclic-AMP and leukotriene B4 production in vitro.
Juergens UR; Stöber M; Libertus H; Darlath W; Gillissen A; Vetter H
Eur J Med Res; 2004 Jul; 9(7):365-70. PubMed ID: 15337638
[TBL] [Abstract][Full Text] [Related]
14. Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells.
Kaur M; Chivers JE; Giembycz MA; Newton R
Mol Pharmacol; 2008 Jan; 73(1):203-14. PubMed ID: 17901197
[TBL] [Abstract][Full Text] [Related]
15. The human near-term myometrial beta 3-adrenoceptor but not the beta 2-adrenoceptor is resistant to desensitisation after sustained agonist stimulation.
Rouget C; Breuiller-Fouché M; Mercier FJ; Leroy MJ; Loustalot C; Naline E; Frydman R; Croci T; Morcillo EJ; Advenier C; Bardou M
Br J Pharmacol; 2004 Mar; 141(5):831-41. PubMed ID: 14769781
[TBL] [Abstract][Full Text] [Related]
16. Synergistic contributions of the functional groups of epinephrine to its affinity and efficacy at the beta2 adrenergic receptor.
Liapakis G; Chan WC; Papadokostaki M; Javitch JA
Mol Pharmacol; 2004 May; 65(5):1181-90. PubMed ID: 15102946
[TBL] [Abstract][Full Text] [Related]
17. Influence of agonist intrinsic activity on the desensitisation of beta2-adrenoceptor-mediated responses in mast cells.
Scola AM; Chong LK; Chess-Williams R; Peachell PT
Br J Pharmacol; 2004 Sep; 143(1):71-80. PubMed ID: 15289287
[TBL] [Abstract][Full Text] [Related]
18. The beta3-adrenoceptor agonist 4-[[(Hexylamino)carbonyl]amino]-N-[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]-phenyl]-benzenesulfonamide (L755507) and antagonist (S)-N-[4-[2-[[3-[3-(acetamidomethyl)phenoxy]-2-hydroxypropyl]amino]-ethyl]phenyl]benzenesulfonamide (L748337) activate different signaling pathways in Chinese hamster ovary-K1 cells stably expressing the human beta3-adrenoceptor.
Sato M; Hutchinson DS; Evans BA; Summers RJ
Mol Pharmacol; 2008 Nov; 74(5):1417-28. PubMed ID: 18684840
[TBL] [Abstract][Full Text] [Related]
19. [Gene transfer of a beta-adrenergic receptor kinase inhibitor up-regulates the level of beta2-adrenergic receptor and cyclic adenosine monophosphate in the asthmatic murine lung].
Huang M; Wu Y; Yao X; Cha WJ; Yin KS
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Nov; 27(11):756-9. PubMed ID: 15634388
[TBL] [Abstract][Full Text] [Related]
20. Agonist occupancy of a single monomeric element is sufficient to cause internalization of the dimeric beta2-adrenoceptor.
Sartania N; Appelbe S; Pediani JD; Milligan G
Cell Signal; 2007 Sep; 19(9):1928-38. PubMed ID: 17561373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
